Zhifeng Xi

805 total citations
37 papers, 501 citations indexed

About

Zhifeng Xi is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Zhifeng Xi has authored 37 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Zhifeng Xi's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer-related molecular mechanisms research (5 papers). Zhifeng Xi is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer-related molecular mechanisms research (5 papers). Zhifeng Xi collaborates with scholars based in China, United States and Japan. Zhifeng Xi's co-authors include Qiang Xia, Kang He, Yixiao Pan, Jianjun Zhang, Qiang Xia, Seogsong Jeong, Hai Wang, Lu Deng, Qiang Xia and Meng Sha and has published in prestigious journals such as Advanced Materials, Oncogene and Frontiers in Immunology.

In The Last Decade

Zhifeng Xi

34 papers receiving 494 citations

Peers

Zhifeng Xi

SURGE

HEPAT

ONCOL

Yunhua Tang China

M. Da Costa Singapore

J. P. Hölzen Germany

Federico Pio Fabrizio Italy

Shen Zhong-yang China

Ying Cheng China

Hirofumi Kanemura Japan

Xingyi Que United States

Feng Su United States

Weitao Que China

Yunhua Tang China

Zhifeng Xi

132 ×0.8

SURGE

144 ×1.0

97 ×0.7

HEPAT

41 ×0.3

ONCOL

107 ×1.0

Citations per year, relative to Zhifeng Xi Zhifeng Xi (= 1×) peers Yunhua Tang

Countries citing papers authored by Zhifeng Xi

Since Specialization

Citations

This map shows the geographic impact of Zhifeng Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifeng Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifeng Xi more than expected).

Fields of papers citing papers by Zhifeng Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifeng Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifeng Xi. The network helps show where Zhifeng Xi may publish in the future.

Co-authorship network of co-authors of Zhifeng Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifeng Xi. A scholar is included among the top collaborators of Zhifeng Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifeng Xi. Zhifeng Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sha, Meng, Jun Wang, Zhifeng Xi, et al.. (2024). Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation. Clinical and Molecular Hepatology. 31(Suppl). S285–S300. 7 indexed citations

Xi, Zhifeng, et al.. (2024). IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma. Journal of Cancer Research and Clinical Oncology. 150(8). 377–377. 1 indexed citations

Dai, Huijuan, Zhifeng Xi, Jiang Zhang, et al.. (2023). HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation. Clinical and Translational Medicine. 13(6). e1283–e1283. 28 indexed citations

Yang, Run, et al.. (2023). Increased Platelet Aggregation in Adults After Orthotopic Liver Transplantation Indicates Higher Probability of Early Postoperative Survival. Annals of Transplantation. 28. e941583–e941583.

Pan, Qi, Yanran Li, Zhifeng Xi, et al.. (2023). Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation. Translational research. 263. 93–101. 3 indexed citations

Zhao, Zhicong, Zhenjun Zhao, Jianye Wang, et al.. (2022). ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 840287–840287. 4 indexed citations

Feng, Hao, Zhifeng Xi, Mureo Kasahara, & Qiang Xia. (2022). Pediatric liver transplantation: progress in optimizing long-term outcomes and directions for future research. Science Bulletin. 67(19). 1929–1931. 1 indexed citations

Xu, Dongwei, Yizhu Tian, Jie Zhao, et al.. (2022). Macrophage Notch1 inhibits TAK1 function and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin signaling in liver ischemia and reperfusion injury. Cell Communication and Signaling. 20(1). 144–144. 19 indexed citations

Jiang, Haowen, Zhifeng Xi, Kang He, et al.. (2022). Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 22 indexed citations

10.

Zhang, Zijie, Huan Tong, Zhifeng Xi, et al.. (2021). Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review. Frontiers in Immunology. 12. 653437–653437. 60 indexed citations

11.

Wang, Hai, Zhifeng Xi, Lu Deng, et al.. (2021). Macrophage Polarization and Liver Ischemia-Reperfusion Injury. International Journal of Medical Sciences. 18(5). 1104–1113. 60 indexed citations

12.

Sha, Meng, Seogsong Jeong, Xin Wang, et al.. (2019). Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma. BMC Cancer. 19(1). 208–208. 23 indexed citations

13.

Xi, Zhifeng, Seogsong Jeong, Chenchen Wang, et al.. (2019). Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection. Hepatobiliary & pancreatic diseases international. 18(3). 242–248. 10 indexed citations

14.

Xi, Zhifeng, et al.. (2018). Clinical analysis of liver transplantation in autoimmune liver diseases. Hepatobiliary & pancreatic diseases international. 17(1). 27–31. 3 indexed citations

15.

Jeong, Seogsong, Qingbao Cheng, Lifeng Huang, et al.. (2017). Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer. 17(1). 464–464. 40 indexed citations

16.

Li, Dawei, Tianfei Lu, Yuan Liu, et al.. (2016). Expression of fibroblast growth factor 21 in patients with biliary atresia. Cytokine. 83. 13–18. 9 indexed citations

17.

Lu, Tianfei, Jiang Zhang, Qi Miao, et al.. (2016). Hypoxia‐inducible factor‐2α promotes hepatocyte apoptosis during cholestasis. Hepatology Research. 47(1). 95–102. 1 indexed citations

18.

Long, Xi‐Dai, Zhifeng Xi, Yun Ma, et al.. (2014). MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis. BioMed Research International. 2014. 1–13. 52 indexed citations

19.

He, Kang, Xiaosong Chen, Qigen Li, et al.. (2013). Quality of life and psychological outcome of donors in pediatric living donor liver transplantation. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 12(9). 681–687. 1 indexed citations

20.

Xi, Zhifeng, Zhuping Fan, Dekai Qiu, & Minde Zeng. (2009). The relationship between fatty liver disease and liver metastases from colorectal cancer. Zhonghua xiaohua zazhi. 29(3). 157–160. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact